UroGen Pharma (URGN) Shares Outstanding (2016 - 2026)
UroGen Pharma's Shares Outstanding came in at 50.38 million for Q2 2026, up 5.5% from 47.74 million a year earlier and up 0.4% from the prior quarter.
Analysis
UroGen Pharma (URGN) Shares Outstanding (2016 - 2026) Analysis & Trends
For FY2025, UroGen Pharma's Shares Outstanding was 48.12 million, up 12.2% from FY2024.
- Shares Outstanding has increased in each of the last ten years, with a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
- Going back by year, Shares Outstanding was 42.88 million in FY2024 (+48.7%), 28.83 million in FY2023 (+26.4%), 22.81 million in FY2022 (+2.1%) and 22.35 million in FY2021 (+2.6%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding in data going back to Q4 2016.
- Year-over-year, Shares Outstanding has increased for 35 consecutive quarters, with growth averaging 23.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 1.5% in Q3 2021 to 56.9% in Q2 2024.
- Business Quant data shows URGN's Shares Outstanding at 50.18 million (Q1 2026), 48.12 million (Q4 2025) and 48.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | UroGen Pharma | 1.99 Bn | 1.49 Bn | 65.88 Mn | 50.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.38 Mn |
| Mar 31, 2026 | 50.18 Mn |
| Dec 31, 2025 | 48.12 Mn |
| Sep 30, 2025 | 48.06 Mn |
| Jun 30, 2025 | 47.74 Mn |
| Mar 31, 2025 | 47.42 Mn |
| Dec 31, 2024 | 42.88 Mn |
| Sep 30, 2024 | 43.10 Mn |
| Jun 30, 2024 | 36.82 Mn |
| Mar 31, 2024 | 33.38 Mn |
| Dec 31, 2023 | 28.83 Mn |
| Sep 30, 2023 | 32.30 Mn |
| Jun 30, 2023 | 23.46 Mn |
| Mar 31, 2023 | 23.28 Mn |
| Dec 31, 2022 | 22.81 Mn |
| Sep 30, 2022 | 22.80 Mn |
| Jun 30, 2022 | 22.70 Mn |
| Mar 31, 2022 | 22.63 Mn |
| Dec 31, 2021 | 22.35 Mn |
| Sep 30, 2021 | 22.38 Mn |
API Access
UroGen Pharma Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=URGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();